[Successful therapy of chronic myelomonocytic leukemia with vp 16-213 (author's transl)].
D000367:Age Factors; D000368:Aged; D002908:Chronic Disease; D005047:Etoposide / Q000627:therapeutic use*; D006098:Granulocytes; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008297:Male; D009000:Monocytes; D011034:Podophyllotoxin / Q000031:analogs & derivatives*
D005047:Etoposide; D011034:Podophyllotoxin
Erfolgreiche Behandlung der chronischen myelomonozytären Leukämie mit VP 16-213.